ArticleOncoTargets and therapy2020

Connexin 43 Modulates the Cellular Resistance to Paclitaxel via Targeting β-Tubulin in Triple-Negative Breast Cancer.

Yun Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.